Group 3 Technologies
Semi-automatic, Guided Intravenous Device
Company Overview
Snapshot
Founded in July 2013 by Alex Wainshtok, Group 3 Technologies operated with 1–10 employees. The company focused on developing a semi-automatic, guided intravenous device, but ceased operations in February 2016.
Business overview
Group 3 Technologies developed SAGIV, a semi-automatic, guided intravenous device designed to improve IV placement. This handheld device incorporates real-time vein display, simple mechanics, and vein penetration sensors, utilizing infrared technology for vein identification and electrical feedback for precise cannulation. The company aimed to serve the healthcare sector by increasing success rates, reducing pain, and optimizing time and cost in medical procedures, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- What is Group 3 Technologies' primary product?
- Group 3 Technologies developed SAGIV, a semi-automatic, guided intravenous device designed for quick and easy IV placement.
- When was Group 3 Technologies founded?
- Group 3 Technologies was founded in July 2013.
- Who is a co-founder of Group 3 Technologies?
- Alex Wainshtok is a co-founder of Group 3 Technologies.
- What technology does SAGIV utilize?
- SAGIV utilizes infrared technology to identify veins for cannulation and electrical feedback for precise vein penetration.
- What was the operational status of Group 3 Technologies?
- Group 3 Technologies ceased to operate in February 2016.